Background: Chronic pain is no longer an effective warning system, but a syndrome with co-morbidities and many causes, needing a careful evaluation. Questions remain about the pain behaviour of chronic pain patients compared with patients with acute pain, or healthy subjects that we investigated. Methods: We compared three populations: healthy (HS, n¼280), with acute pain (AP¼110 patients), and chronic pain (CP¼280 patients) by assessing their pain behaviour with the pain sensitivity questionnaire (PSQ-total and PSQ-minor). The influence of central sensitisation syndrome (CSS) on chronic pain behaviour, including catastrophising, was further investigated by using the central sensitisation inventory. Results: Compared with the AP patients and HS, the CP patients exhibited significantly higher catastrophising scores; higher PSQ-minor scores [29.0 (21.0e39.0), than for AP 24.0 (14.0e32.5), and for healthy subjects 25.0 (17.0e34.0); and PSQtotal scores of for CP, 63.5 for AP, and 64.0 for HS. No significant difference was observed between the HS and AP populations. Significant differences were observed between the CP patients with and without CSS. The median PSQ-minor for patients with CSS was 33.0 and without CSS was 25.0 (P<0.05); the median PSQ-total for patients with CSS was 82.0 and without CSS was 65 (P<0.05). The CP patients without CSS did not show any significant difference compared with the AP and HS groups, except for catastrophising. Conclusions: This study highlights the influence of CSS in the results of PSQ and catastrophising by chronic pain patients in comparison with healthy controls and acute pain patients. Clinical trial registration: P2014/134.
Editor's key points
Patients with chronic pain may have altered neurobiology of peripheral and central nervous systems. Identifying these differences using validated questionnaires may be useful for directing management. This study explored potential differences in central responses between healthy volunteers, and acute and chronic pain. Chronic pain patients with central sensitisation showed different responses compared with the other groups. Further work is needed to understand the clinical significance of this and the implications for management.
Acute pain may evolve to chronicity. In such cases, pain is no longer an effective warning system, protecting us from illness or injury, but becomes a syndrome, with multiple clinical, psychological, and social repercussions. 1 Subjects with chronic pain tend to have a much poorer quality of life, often suffering from anxiety, depression, and poor sleep. 1, 2 Experimental measurements of pain perception in chronic pain patients (CP) are characterised by localised and generalised increases in pain perception, 3 a phenomenon resulting from pathophysiological states, such as central sensitisation (CS), 4 as assessed by the central sensitisation inventory (CSI), 5, 6 a self-report inventory. 7e9 Ruscheweyh and colleagues 3, 10 have recently presented the pain sensitivity questionnaire (PSQ) for the assessment of pain perception in chronic pain syndromes, such as chronic tension-type headache, low back pain, painful temporomandibular disorder, and mixed chronic pain. 3 Nevertheless, questions remain about pain behaviour and its differences. To evaluate the presence or absence of painbehaviour similarities amongst chronic pain disorders, we used the PSQ on CP during their first evaluation in our multidisciplinary pain centre, which also includes some aspect of the assessment of catastrophising. The pain catastrophising scale (PCS) 11 is indeed used routinely in our preoperative setting for all patients requiring surgery. The robustness of this multi-aspect scale in regard to its predictive factors related to pain makes it a useful tool in this setting. Our ultimate purpose was to identify differences in central nociceptive processing between CP, based on the CSI, and both healthy subjects (HS) and acute pain patients (AP).
Methods
The study was approved by the local ethics committee at the Hospital Erasme, Free University of Brussels, in accordance with the Declaration of Helsinki.
Subjects

Chronic pain patients
Patients recruited in our multidisciplinary evaluation and treatment pain centre from October 2014 to September 2015 completed the questionnaires during their first contact evaluation. Those patients, referred to our centre by generalists or other specialists, presented with pain for a minimum period of 3 months.
Acute pain patients
AP were defined as those with nociceptive pain for less than 2 months, and waiting for orthopaedic surgery or spine surgery.
Healthy subjects
HS without chronic pain or frequent pain conditions were recruited in our institution. The following criteria were required for all participants: age >18 yr, knowledge of the French language, ability to fill in the questionnaires, participation agreement, absence of substance abuse, and absence of chronic renal or liver failure or pregnancy.
Pain sensitivity questionnaire
The PSQ is composed of 17 items, each describing a daily life situation, asking the subjects to rate their pain on a numeric rating scale (NRS) ranging from 0 (not painful at all) to 10 (worst pain imaginable). 3 This questionnaire is referred to as PSQ-total (Items 1e4, 6e8, 10e12, and 14e17) and its sub-score, PSQ-minor (3, 6, 7, 10, 11, 12, and 14) , in this study.
Pain catastrophising scale
The PCS, developed in 1995 by Sullivan and Bishop, 11 is composed of 13 items describing different feelings and thoughts associated with pain. The PCS takes into account the past painful experiences to indicate the frequency and degree to which the patient experienced pain for each item on an NRS ranging from 0 (not at all) to 4 (all the time); the PCS thus yields a maximum total score of 52. Three more sub-scale scores assessing either rumination (tendency to focus on pain) (Items 8e11), magnification (exaggeration of perceived pain-related threat) (Items 6, 7, and 13), or helplessness (feeling to be helpless to cope effectively with pain) (Items 1e5 and 12) can also be recorded. Higher scores are associated with an increased risk for chronic pain. 11e14 The use of PCS is a daily practice in our hospital in the preoperative setting and management of chronic pain.
Central sensitisation inventory
The CSI is a patient-reported outcome score that assesses 25 somatic and emotional symptoms common to central sensitisation syndromes (CSSs). Each item ranges from 0 to 4, with a total of 0e100. The use of the CSI is recommended to classify CP according to whether CSS is susceptible or not, the cut-off score being set at 40. 5, 6 This measure was used in our study, in the chronic patient group, to distinguish the patients with CSS from those without.
Results
Patient characteristics
The characteristics of the study population are shown in Table 1 . As we prospectively analysed the population admitted in our multidisciplinary pain centre, differences were observed in patient characteristics, with a higher number of women in all of the groups and subgroups. Patients in the AP group were older than the patients from the other groups. This clearly reflects our clinical practice.
Comparison of the PSQ-minor and the PSQ-total between the three different populations CP exhibited significantly higher PSQ-total and PSQ-minor scores than those issued from the AP or HS groups. No significant difference was observed between the HS and AP populations concerning these scores ( Table 2) .
Comparison of the PCS and its three sub-scales between the three different populations CP exhibited significantly higher PCS scores than those issued from the AP or HS group. The same trends were also observed for its three sub-scales (i.e. rumination, magnification, and helplessness). No significant difference was observed between the HS and AP populations concerning these scores (Table 3) .
Pain behaviour between different chronic pain disorders
Central sensitisation inventory
Patients with chronic primary pain, chronic neuropathic pain, chronic post-surgical and post-traumatic pain, chronic headache and orofacial pain, chronic visceral pain, and complex regional pain syndrome had a CSI greater than 40 (total of 159 patients), and were then considered as CP with CSS, whilst patients with chronic musculoskeletal pain (n¼121) had a CSI less than 40 and were included in the CP without CSS group ( Table 1) .
Influence of the CSI on the PSQ and PCS scores
For PSQ-total and PSQ-minor scores, only the CP patients with CSS showed a significantly different scoring result. All of the other groups (CP without CSS, AP, and HS) had similar results with regard to the different pain scores (Table 4) . For PCS and its three sub-scales, the CP patients with and without sensitisation exhibited higher scores in comparison with AP and HS (Tables 5 and 6 ). A significant difference was also found between the CP patients with CS and those without, the former showing higher scores than the latter.
Discussion
Our study, using the PSQ, PCS, and CSI in two groups of patients, having either acute pain or chronic pain, compared with a control group, is, to our knowledge, the first to show that CP with a CS behaves differently regarding pain sensitivity, compared with the HS and AP, and also in comparison with CP without CS. These chronic pain syndromes with CSS disorders include complex regional pain syndrome, chronic primary pain, chronic neuropathic pain, chronic post-surgical and post-traumatic pain, chronic headache and orofacial pain, chronic visceral pain, and chronic musculoskeletal pain, a classification of chronic pain for International Classification of Disease, Eleventh Revision having been published by Treede and colleagues. 15 It is repeatedly described that patients suffering from chronic pain attributable to various causes demonstrate a generalised elevation of experimentally assessed pain perception.
16e21 CSS is characterised by excitatory modulation of the somatosensory system, with increased activity of pain facilitation pathways, and a malfunctioning of the descending pain inhibitory pathways. 22e26 Nevertheless, the question remained about the reality of a similar behaviour between those different chronic pain syndromes. In our study, with the exception of the patients with chronic musculoskeletal pain, all CP had a CSI score greater than 40, strongly suggesting the influence of the CS process in these groups. 5, 6 Pain sensitivity questionnaire Ruscheweyh and colleagues 3 showed significant correlations between PSQ scores and the results of experimental pain testing in CP. Patients suffering from chronic pain exhibited increased PSQ scores as compared with healthy controls. Our results strengthen those of previous studies published using the PSQ, 3,10 with higher scores in the chronic pain group in comparison with HS and AP, but differences were also present in the CP group, related to the presence or not of CS. The PSQtotal and PSQ-minor scores in CP with a CS behave differently regarding their pain sensitivity, compared with the HS and AP, and also in comparison with CP without CS. Interestingly, patients with pathologies responsible for chronic musculoskeletal pain behave similarly to the AP and HS. In earlier studies with HS, experimental pain intensity rating scores were more strongly correlated with the PSQminor sub-score than with the PSQ-total score. Nevertheless, authors mostly recommend that both the PSQ-total score and the PSQ-minor sub-score should be collected. 3, 10 Bearing this in mind, we used both PSQ-total and PSQ-minor in our study, and observed similar trends in the differences in pain behaviour between CP patients with and without CS. However, evaluating the strength of these scores is beyond the scope of this study, and we will continue to use its minor and total versions. 
Pain catastrophising scale
Our study is the first to demonstrate that CP patients with and without CS exhibited higher PCS, rumination, magnification, and helplessness scores, in comparison with AP patients and HS. Pain catastrophising, 11e14 defined previously by its three main components: predisposition to rumination, magnification, and helplessness, is a robust predictor of pain adjustment, distress, and severity amongst patients with chronic pain.
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Craner and colleagues, 27 using the same scaling, found that either rumination or helplessness or even the three sub-scales were associated with disability ratings. When neuropathic pain was specially considered, helplessness was the only subscale explaining a different behaviour. 28 Using different endpoints, others have found that helplessness was the only factor accounting for pain severity, painrelated interference, mental-health-related quality of life, and depressed mood, and that magnification could also predict physical-and mental-health-related quality of life, and depressed mood. 29, 30 Similar results were found with helplessness, probably subsequent to a repercussion of poor adaptation to life's difficulties in general and their consequences, such as anxiety, depression, and passive coping style. 31 Another finding of our study is that, when considering only the CP patients, those with CS had also higher scores than those without CS; the difference is greater for the magnification and helplessness sub-scales than for the rumination.
These findings have not yet been discussed elsewhere in the literature and need to be more deeply studied.
However, these new observations could modify the concept of the actually proposed treatments and should induce further investigation. Indeed, studies 32e34 showed that partial posttreatment improvements were observed in both pain severity and interference, and in depressive symptoms, with approaches targeting mostly rumination and helplessness, whilst a decrease in magnification influenced essentially the mental-health-related quality-of-life outcome in different categories such as fibromyalgia, and back pain. The higher scores for PCS and its three sub-scales in our study, and in the chronic patient group with CS than without CS strongly reinforce the need for studies re-evaluating the post-treatment evolution of these various outcomes in relation with CS. 
PSQ, PCS, and CS
Whilst PSQ scores were only higher in the CP with CS group, PSQ scores were higher as well in the CP with CS as in the CP without CS groups, marking a difference in the way these questionnaires evaluate pain behaviour in chronic pain. These differences were also present in regard to the PCS sub-scales, statistically more significant for magnification and helplessness than for rumination. These results, in conjunction to the pre-existing studies, strengthen the need for further investigations related to CS.
What is next?
Some studies suggest that chronic pain induces morphological and plastic changes in the brain, 35, 36 with an increased activity in brain areas, such as the insula, anterior cingulate cortex, prefrontal cortex, various brainstem nuclei, dorsolateral frontal cortex, and parietal associated cortex, but only scarce data exist linking these changes to clinically relevant functional alterations.
Wolrich and colleagues 37 recently demonstrated increased errors in number marking and naming in patients with CP in comparison with patients with AP and healthy controls. Practical consequences of number-sense impairment include questioning regarding the clinical use of the visual analogue scale and the NRS, tools that require participants to have unaltered cognitive function. 5 This suggests that the results using these scales in CP should be used with caution. Whether all chronic pain syndromes induce number-sense impairment because of increased measurement inaccuracy is unknown. Our study suggests that this point should be tested in chronic pain patient groups with or without a CSS. We will plan to address this point in the future.
Study limitations
Whilst our daily practice with CP includes the use of multiple measures focusing on anxiety, depression, and quality of life, those were not used in this study. Indeed, AP and HS were not evaluated with these tools. Many questions remain, especially in regard to the differences observed in pain behaviour and between the questionnaires used, clearly needing further investigations as well in our approach of the three sub-scales of PCS as in the type of treatments we should propose to our painful patients.
This study highlights the clinically relevant influence of underlying pain disorders, as evidenced by the results of the PSQ in CP in comparison with HS and AP. Both PSQ-minor and PSQ-total scores are increased in CP with CSSs, whilst no difference was observed in the scores between CP without CSS, AP, and healthy controls. On the contrary, the PCS scores and its three sub-scales were higher as well in CP with and without CS, in comparison with AP and healthy controls. Further investigation should explore how multidisciplinary paintreatment approaches focusing on CS and the different dimensions of pain catastrophising, including the magnification component, could change the outcomes of pain.
